Daybue turned Neuren into a biotech heavyweight. Now investors want to know whether the company’s next wave of rare disease drugs can repeat the trick.
Sale of a portion of Ariana Resources’ stake in Turkish gold producer Zenit will accelerate development of its flagship Dokwe gold project in Zimbabwe.
